Abstract
A case of stage IB2 cervical cancer at 27 weeks of pregnancy, treated with neoadjuvant chemotherapy followed by radical Cesarean hysterectomy with full pelvic and infra-mesenteric lymphadenectomy, and adjuvant chemo-radiation is described. While she remains without disease, her baby was diagnosed with acute myelogenous leukemia. We highlight the pre-operative work-up, treatment options, safety, feasibility, and outcomes for the mother and her fetus.
Lingua originale | English |
---|---|
pagine (da-a) | 398-405 |
Numero di pagine | 8 |
Rivista | Gynecologic Oncology |
Volume | 150 |
DOI | |
Stato di pubblicazione | Pubblicato - 2018 |
Keywords
- Adult
- Antineoplastic Combined Chemotherapy Protocols
- Carcinoma, Squamous Cell
- Cervical cancer
- Cesarean Section
- Chemotherapy, Adjuvant
- Cisplatin
- Female
- Humans
- Hysterectomy
- Infant, Newborn
- Male
- Neoadjuvant Therapy
- Neoadjuvant chemotherapy
- Neoplasm Staging
- Obstetric outcome
- Obstetrics and Gynecology
- Oncology
- Paclitaxel
- Pregnancy
- Pregnancy Complications, Neoplastic
- Radical hysterectomy
- Salpingectomy
- Uterine Cervical Neoplasms